Unity Biotechnology
UBX
$1.61
Share price
-1.23%
Change (1 day)
-29.39%
Change (1 year)
Categories
Unity Biotechnology (UBX) - P/B ratio
P/B ratio as of May 2024 : 0.9635
According to Unity Biotechnology
's latest financial reports the company has a price-to-book ratio of 0.9635.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Unity Biotechnology - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.14 | 64.52% |
| 2022-12-31 | 0.6934 | -50.99% |
| 2021-12-31 | 1.41 | -57.71% |
| 2020-12-31 | 3.35 | 18.59% |
| 2019-12-31 | 2.82 | -34.27% |
| 2018-12-31 | 4.29 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | 197.28% | 🇺🇸 USA |